Conducting and supporting education, research and the advancement of knowledge and public awareness of stem cell therapy and regenerative medicine.

Find Out What We’re About Make A Donation Today

Mission and Vision

The International Cell Surgical Society (ICSS) is a US-based, 501c3 nonprofit organization with the mission of advancing the safe and effective use of autologous, stromal vascular fraction (SVF) as part of the practice of medicine

Institutional Review Board

As part of its mission, the ICSS maintains and manages an HHS registered Institutional Review Board to review new and innovative medical therapies and proposed clinical studies

Patient Safety

Paramount to the advancement of innovative medicine is the protection of the safety of all patients. To aid in this mission, the ICSS has developed a rigorous sub-investigator proficiency and accreditation standards

Advancing Cell Medicine

The promise of cell-based therapies has never been greater. The ICSS was founded to work with physicians and patients to realize this promise and deliver on the hope that we can use the body’s own repair mechanisms to treat chronic and degenerative diseases

Want to find out more? Fill out the form below:

News & Updates

CSN Meeting

ICSS is pleased to announce its collaboration with Cell Surgical Network (CSN) in presenting the 4th Annual CSN Meeting in 2017.  For the second year in a row, ICSS and CSN will be able to bring together the leading clinicians behind the groundbreaking techniques using adipose-derived stem cells, including didactic lectures from CSN founders Dr.…

ICSS Proud to Announce Publication of CSN Safety Data

The Cell Surgical Network is proud to have published one of the largest peer reviewed safety data papers on the use of autologous stromal vascular fraction (SVF) to date. SVF contains adult adipose-derived mesenchymal stem cells that many scientific publications have long suggested could be used for regenerative medical purposes. The Cell Surgical Network set…

Cell Expansion Study Approved

Cell Surgical Network (CSN) has partnered with American Cryostem (ACS) and has recently received approval from ICSS to study the safety of banking and expanding adipose derived stromal vascular fraction.  Both companies see this as the future of regenerative medicine: bank young healthy cells and have them available when injury or illness occur.  A practice…